EV/Sales is the capital-structure-neutral valuation lens that puts equity and debt holders on the same footing. Learn how to read the multiple correctly — using Titan Biotech's FY25 audited ₹214 Cr revenue, ₹3 Cr borrowings, and 103% CFO/OP cash conversion as an educational illustration of management discipline.